Drug utilization studies among ENT patients in various clinical settings: A comprehensive review
Drug utilization research is thus an all important part of pharmacoepideminology as it explains the extent, nature and determinants of drug exposure. A drug utilization study is a tool for determining the effectiveness of drug use. They have tendency to create sound economic bases for health care. It focuses on various factors related to prescribing, dispensing, and administration of medication and associated events. It is a study which is used for analyzing or describe-quantitatively and qualitatively- the population of users of a given drug (or class of drug) and/or the condition of use (for example, indication, duration of treatment, dosage, previous or associated treatment and compliance). ENT problems have been counted as prominent as well as commonly occurring medical problem for our society. It is a problem of most concern. Drug utilization studies can play a major role to identify the nature of therapy used in their treatment and also helps to promote the rationality and minimizing the errors in the drug therapy. Such kind of studies can be helpful for healthcare practitioners as well as to the society against such health issues. Drug utilization research developed quickly during the following 30 years and soon became a respectable subject for consideration at international congresses in pharmacology, pharmacy and epidemiology. Successful research in drug requires multidisciplinary collaboration between clinicians, clinical pharmacologists, pharmacists and epidemiologists. Without the support of the prescribers, this research effort will fail to reach its goal of facilitating the rational use of drugs. In this review, we will briefly list various Drug utilization studies in ENT Clinical settings.
Keywords: Drug utilization studies, ENT, Prescribing patterns, Rational prescribing, Pharmacoepideminology
2. WHO expert committee. The selection of essential drug, technical report series no. 615 2-Geneva: World Health Organization, 1977.
3. Maniyar Y, Bhixavatimath P, Akkone V. A drug utilization study in the Ophthalmology department of a Medical College, Karnataka, India. Journal of clinical and diagnostic research 2011; 5(1):82-84.
4. Holloway K, Green T. Drug and therapeutics committees – A practical guide. Geneva: World Health Organization 2003; 71-94.
5. Njoroge NG, Bussmann RW. Traditional management of ear, nose and throat disease in central Kenya. Journal of Ethnobiology and Ethnomedicine 2006; 2:54.
6. Mark S, Dykewicz, MD, and Hamilos LD. Rhinitis and Sinusitis .New England Journal of Medicine; 125(2): S103-S115.
7. Ilechukwu GC, Ilechukwu CGA. UbesieAC, Ojinnaka CN, Emechebe GO, Iloh K.K Open Journal of Pediatrics, 2014; 4:47-53.
8. Sathiya SB, Panchasara AK, Barvaliya MJ, Jha SG, Tripathi CB. Drug utilization pattern of antimicrobial agents in an outpatient department of otorhinolaryngology in a tertiary care hospital: a prospective, cross-sectional study. International journal of basic and clinical pharmacology 2015; 5:65-69.
9. Nitasha GM, Holla R, Shrinath DK. A study of prescription pattern in the drug therapy of ear, nose, and throat infections at a tertiary care hospital in Mangalore. International journal of basic and clinical pharmacology 2015; 4(4):686-690.
10. Kalpana S, Bhattacharjya D, Barman H, Goswami SC. Common ear, nose and throat problems in pediatric age group presenting to the emergency clinic- prevalence and management: A hospital based survey. Indian journal of Clinical Practice 2014; 24(8):756-760.
11. Vishwanath M, Narayana RS, Devadas S. Assessment of drug utilization in hospitalized children at a tertiary care teaching hospital. Journal of Chemical and Pharmaceutical Research 2014; 6(2): 592-598.
12. Piromchai P, Thanaviratananich S. Impact of treatment time on the survival of patients suffering from invasive fungal rhinosinositis. A journal of Clinical medical insights: Ear, Nose, and Throat 2014; 7:31-34.
13. Goud KS, Thndu, Kumar R, Vithal G, Patel, Dighe D, Lalan HN, Singh A. Drug utilization pattern in upper respiratory tarct infections in ENT OPD of tertiary care hospital. Indian journal of applied research 2014; 4(2).
14. Venkateshwaramurthy N, Murali R, Kumar RS. The study of drug utilization pattern in pediatric patients. International Journal of Pharmacy and Pharmaceutical Sciences 2013; 5(3):140-144.
15. Thamby et al., International Current Pharmaceutical Journal 2012, 1(11):353-360.
16. Gupta AS, Ram R, Islam F. A study on clinico-epidemiological profiles of ear, throat and nose diseases among patients aged 6-14 years. Global Journal of medicine and public health 2012; 1(4):13-17.
17. Sivakumar P, Abdu RT, Perumal P. Drug utilization pattern of antimicrobials ion ENT Pateints. Asian Journal of Pharmaceutical and Clinical Research 2011; 4(l1):123-125.
18. Ain MR, Shahzad N, Aqil M. Drug utilization pattern of antibacterials used in ENT out-patient and in-patient department. Journal of Pharmacy and bioallied sciences 2010; 2(1):8-15.
19. Yadav P, Kanase V, Lacchiramka P. Drug utilization trends in ENT out-patient department in a teaching hospital. International Journal of Pharma and Biosciences. 2010; 1(4):153-160.
20. Panznera P, Malkusovaa I, Vachovaa M, Liskaa M, Brodskab P, Ruzickovac O, Maly M. Bronchial inflammation in seasonal allergic rhinitis with or withoutasthma in relation to natural exposure to pollen allergens. Allergol Immunopathol (Madr). 2015; 43(1):3-9.
21. Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, Takenaka H. Japanese Guideline for Allergic Rhinitis 2014. Allergology International. 2014; 63:357-375.
22. Lambert L. Is it flu or allergy. S Afr Pharm J 2014; 81(4):20-25.
23. Joshi S, Dimov VES. Use of new technology to improve utilization and adherence to immunotherapy. World Allergy Organization Journal 2014; 7(29):2-6.
24. Honda K, Saito H, Fukui N, Ito E, Ishikawa K. The Relationship between Pollen Count Levels and Prevalence of Japanese Cedar Pollinosis in Northeast Japan. Allergology International 2013; 62:375-380.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).